Home » Pharma & Healthcare » Global Long-Acting Injectabl Market 2021 by Player, Region, Type, Application and Sales Channel

Global Long-Acting Injectabl Market 2021 by Player, Region, Type, Application and Sales Channel

  116 Pages     Pharma & Healthcare  

Available Formats      

Report ID: 86557
Published By: MAResearch

Summary

The Global Long-Acting Injectabl Market was valued at $XX million in 2020, and research analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2021 and 2030.

This report studies the Long-Acting Injectabl market, covering market size for segment by type (First-generation LAIs, Second-generation LAIs, etc.), by application (Schizophrenia, Contraception, etc.), by Sales Channel (Direct Channel, Distribution Channel), by player (Eli Lilly, Alkermes, Johnson & Johnson, Zogenix, DURECT, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Long-Acting Injectabl from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Long-Acting Injectabl market.

Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of Long-Acting Injectabl including:

  • Eli Lilly
  • Alkermes
  • Johnson & Johnson
  • Zogenix
  • DURECT
  • Mapi Pharma
  • GSK
  • Medincell
  • Oakwood Labs
  • Nanomi
  • Pharmathen
  • Kashiv BioSciences
  • Pfizer
  • Lupin Limited

Market split by Type, can be divided into:

  • First-generation LAIs
  • Second-generation LAIs

Market split by Application, can be divided into:

  • Schizophrenia
  • Contraception
  • HIV
  • Others

Market split by Sales Channel, can be divided into:

  • Direct Channel
  • Distribution Channel

Market segment by Region/Country including:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Spain etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
  • South America (Brazil, Argentina and Colombia etc.)
  • Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

Chapter 1 Long-Acting Injectabl Market Overview

1.1 Long-Acting Injectabl Definition

1.2 Global Long-Acting Injectabl Market Size Status and Outlook (2015-2030)

1.3 Global Long-Acting Injectabl Market Size Comparison by Region (2015-2030)

1.4 Global Long-Acting Injectabl Market Size Comparison by Type (2015-2030)

1.5 Global Long-Acting Injectabl Market Size Comparison by Application (2015-2030)

1.6 Global Long-Acting Injectabl Market Size Comparison by Sales Channel (2015-2030)

1.7 Long-Acting Injectabl Market Dynamics (COVID-19 Impacts)

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Mergers/Acquisitions/Expansion)

1.7.4 COVID-19 Impacts on Current Market

1.7.5 Post-Strategies of COVID-19 Outbreak

Chapter 2 Long-Acting Injectabl Market Segment Analysis by Player

2.1 Global Long-Acting Injectabl Sales and Market Share by Player (2018-2020)

2.2 Global Long-Acting Injectabl Revenue and Market Share by Player (2018-2020)

2.3 Global Long-Acting Injectabl Average Price by Player (2018-2020)

2.4 Players Competition Situation & Trends

2.5 Conclusion of Segment by Player

Chapter 3 Long-Acting Injectabl Market Segment Analysis by Type

3.1 Global Long-Acting Injectabl Market by Type

3.1.1 First-generation LAIs

3.1.2 Second-generation LAIs

3.2 Global Long-Acting Injectabl Sales and Market Share by Type (2015-2020)

3.3 Global Long-Acting Injectabl Revenue and Market Share by Type (2015-2020)

3.4 Global Long-Acting Injectabl Average Price by Type (2015-2020)

3.5 Leading Players of Long-Acting Injectabl by Type in 2020

3.6 Conclusion of Segment by Type

Chapter 4 Long-Acting Injectabl Market Segment Analysis by Application

4.1 Global Long-Acting Injectabl Market by Application

4.1.1 Schizophrenia

4.1.2 Contraception

4.1.3 HIV

4.1.4 Others

4.2 Global Long-Acting Injectabl Revenue and Market Share by Application (2015-2020)

4.3 Leading Consumers of Long-Acting Injectabl by Application in 2020

4.4 Conclusion of Segment by Application

Chapter 5 Long-Acting Injectabl Market Segment Analysis by Sales Channel

5.1 Global Long-Acting Injectabl Market by Sales Channel

5.1.1 Direct Channel

5.1.2 Distribution Channel

5.2 Global Long-Acting Injectabl Revenue and Market Share by Sales Channel (2015-2020)

5.3 Leading Distributors/Dealers of Long-Acting Injectabl by Sales Channel in 2020

5.4 Conclusion of Segment by Sales Channel

Chapter 6 Long-Acting Injectabl Market Segment Analysis by Region

6.1 Global Long-Acting Injectabl Market Size and CAGR by Region (2015-2030)

6.2 Global Long-Acting Injectabl Sales and Market Share by Region (2015-2020)

6.3 Global Long-Acting Injectabl Revenue and Market Share by Region (2015-2020)

6.4 North America

6.4.1 North America Market by Country

6.4.2 North America Long-Acting Injectabl Market Share by Type

6.4.3 North America Long-Acting Injectabl Market Share by Application

6.4.4 United States

6.4.5 Canada

6.4.6 Mexico

6.5 Europe

6.5.1 Europe Market by Country

6.5.2 Europe Long-Acting Injectabl Market Share by Type

6.5.3 Europe Long-Acting Injectabl Market Share by Application

6.5.4 Germany

6.5.5 UK

6.5.6 France

6.5.7 Italy

6.5.8 Russia

6.5.9 Spain

6.6 Asia-Pacific

6.6.1 Asia-Pacific Market by Country

6.6.2 Asia-Pacific Long-Acting Injectabl Market Share by Type

6.6.3 Asia-Pacific Long-Acting Injectabl Market Share by Application

6.6.4 China

6.6.5 Japan

6.6.6 Korea

6.6.7 India

6.6.8 Southeast Asia

6.6.9 Australia

6.7 South America

6.7.1 South America Market by Country

6.7.2 South America Long-Acting Injectabl Market Share by Type

6.7.3 South America Long-Acting Injectabl Market Share by Application

6.7.4 Brazil

6.7.5 Argentina

6.7.6 Colombia

6.8 Middle East & Africa

6.8.1 Middle East & Africa Market by Country

6.8.2 Middle East & Africa Long-Acting Injectabl Market Share by Type

6.8.3 Middle East & Africa Long-Acting Injectabl Market Share by Application

6.8.4 UAE

6.8.5 Saudi Arabia

6.8.6 South Africa

6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Long-Acting Injectabl Players

7.1 Eli Lilly

7.1.1 Company Snapshot

7.1.2 Product/Service Offered

7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

7.1.4 COVID-19 Impact on Eli Lilly

7.2 Alkermes

7.3 Johnson & Johnson

7.4 Zogenix

7.5 DURECT

7.6 Mapi Pharma

7.7 GSK

7.8 Medincell

7.9 Oakwood Labs

7.10 Nanomi

7.11 Pharmathen

7.12 Kashiv BioSciences

7.13 Pfizer

7.14 Lupin Limited

Chapter 8 Upstream and Downstream Analysis of Long-Acting Injectabl

8.1 Industrial Chain of Long-Acting Injectabl

8.2 Upstream of Long-Acting Injectabl

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.2.4 Manufacturing Cost Structure

8.2.5 Manufacturing Process

8.3 Downstream of Long-Acting Injectabl

8.3.1 Leading Distributors/Dealers of Long-Acting Injectabl

8.3.2 Leading Consumers of Long-Acting Injectabl

Chapter 9 Development Trend of Long-Acting Injectabl (2021-2030)

9.1 Global Long-Acting Injectabl Market Size (Sales and Revenue) Forecast (2021-2030)

9.2 Global Long-Acting Injectabl Market Size and CAGR Forecast by Region (2021-2030)

9.3 Global Long-Acting Injectabl Market Size and CAGR Forecast by Type (2021-2030)

9.4 Global Long-Acting Injectabl Market Size and CAGR Forecast by Application (2021-2030)

9.5 Global Long-Acting Injectabl Market Size and CAGR Forecast by Sales Channel (2021-2030)

Chapter 10 Appendix

10.1 Research Methodology

10.2 Data Sources

10.3 Disclaimer

10.4 Analysts Certification

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

Figure Long-Acting Injectabl Example

Figure Global Long-Acting Injectabl Revenue (Million $) Status and Outlook (2015-2030)

Figure Global Long-Acting Injectabl Revenue (Million $) Comparison by Region (2015-2030)

Figure Global Long-Acting Injectabl Revenue (Million $) Comparison by Type (2015-2030)

Figure Global Long-Acting Injectabl Revenue (Million $) Comparison by Application (2015-2030)

Figure Global Long-Acting Injectabl Revenue (Million $) Comparison by Sales Channel (2015-2030)

Table Global Long-Acting Injectabl Sales by Player (2018-2020)

Table Global Long-Acting Injectabl Sales Market Share by Player (2018-2020)

Figure Global Long-Acting Injectabl Sales Market Share by Player in 2020

Table Global Long-Acting Injectabl Revenue (Million $) by Player (2018-2020)

Table Global Long-Acting Injectabl Revenue Market Share by Player (2018-2020)

Figure Global Long-Acting Injectabl Revenue Market Share by Player in 2020

Table Global Long-Acting Injectabl Average Price by Player (2018-2020)

Figure Global Long-Acting Injectabl Average Price by Player in 2020

Figure Global Long-Acting Injectabl Players Competition Situation – Top 5 Players’ Revenue Market Share in 2018

Figure Global Long-Acting Injectabl Players Competition Trends – Top 5 Players’ Revenue Market Share in 2020

Figure Example of First-generation LAIs

Figure Global First-generation LAIs Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of Second-generation LAIs

Figure Global Second-generation LAIs Revenue (Million $) and Growth Rate (2015-2020)

Table Global Long-Acting Injectabl Sales by Type (2015-2020)

Table Global Long-Acting Injectabl Sales Market Share by Type (2015-2020)

Figure Global Long-Acting Injectabl Sales Market Share by Type in 2020

Table Global Long-Acting Injectabl Revenue (Million $) by Type (2015-2020)

Table Global Long-Acting Injectabl Revenue Market Share by Type (2015-2020)

Figure Global Long-Acting Injectabl Revenue Market Share by Type in 2020

Table Global Long-Acting Injectabl Average Price by Type (2015-2020)

Figure Global Long-Acting Injectabl Average Price by Type in 2020

Table Leading Players of Long-Acting Injectabl by Type in 2020

Figure Example of Schizophrenia

Figure Global Long-Acting Injectabl for Schizophrenia Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of Contraception

Figure Global Long-Acting Injectabl for Contraception Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of HIV

Figure Global Long-Acting Injectabl for HIV Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of Others

Figure Global Long-Acting Injectabl for Others Revenue (Million $) and Growth Rate (2015-2020)

Table Global Long-Acting Injectabl Sales by Application (2015-2020)

Table Global Long-Acting Injectabl Sales Market Share by Application (2015-2020)

Figure Global Long-Acting Injectabl Sales Market Share by Application in 2020

Table Leading Consumers of Long-Acting Injectabl by Application in 2020

Figure Example of Direct Channel

Figure Global Long-Acting Injectabl for Direct Channel Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of Distribution Channel

Figure Global Long-Acting Injectabl for Distribution Channel Revenue (Million $) and Growth Rate (2015-2020)

Table Global Long-Acting Injectabl Revenue by Sales Channel (2015-2020)

Table Global Long-Acting Injectabl Revenue Market Share by Sales Channel (2015-2020)

Figure Global Long-Acting Injectabl Revenue Market Share by Sales Channel in 2020

Table Leading Distributors/Dealers of Long-Acting Injectabl by Sales Channel in 2020

Table Global Long-Acting Injectabl Market Size and CAGR by Region (2015-2030)

Table Global Long-Acting Injectabl Sales by Region (2015-2020)

Table Global Long-Acting Injectabl Sales Market Share by Region (2015-2020)

Figure Global Long-Acting Injectabl Sales Market Share by Region in 2020

Table Global Long-Acting Injectabl Revenue (Million $) by Region (2015-2020)

Table Global Long-Acting Injectabl Revenue Market Share by Region (2015-2020)

Figure Global Long-Acting Injectabl Revenue Market Share by Region in 2020

Table North America Long-Acting Injectabl Sales by Country (2015-2020)

Figure North America Long-Acting Injectabl Sales Market Share by Country (2015-2020)

Table North America Long-Acting Injectabl Revenue by Country (2015-2020)

Figure North America Long-Acting Injectabl Revenue Market Share by Country (2015-2020)

Figure North America Long-Acting Injectabl Market Share by Type in 2020

Figure North America Long-Acting Injectabl Market Share by Application in 2020

Figure United States Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure United States Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Canada Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Canada Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Mexico Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Mexico Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Table Europe Long-Acting Injectabl Sales by Country (2015-2020)

Figure Europe Long-Acting Injectabl Sales Market Share by Country (2015-2020)

Table Europe Long-Acting Injectabl Revenue by Country (2015-2020)

Figure Europe Long-Acting Injectabl Revenue Market Share by Country (2015-2020)

Figure Europe Long-Acting Injectabl Market Share by Type in 2020

Figure Europe Long-Acting Injectabl Market Share by Application in 2020

Figure Germany Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Germany Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure UK Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure UK Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure France Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure France Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Italy Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Italy Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Russia Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Russia Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Spain Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Spain Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Table Asia-Pacific Long-Acting Injectabl Sales by Country (2015-2020)

Figure Asia-Pacific Long-Acting Injectabl Sales Market Share by Country (2015-2020)

Table Asia-Pacific Long-Acting Injectabl Revenue by Country (2015-2020)

Figure Asia-Pacific Long-Acting Injectabl Revenue Market Share by Country (2015-2020)

Figure Asia-Pacific Long-Acting Injectabl Market Share by Type in 2020

Figure Asia-Pacific Long-Acting Injectabl Market Share by Application in 2020

Figure China Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure China Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Japan Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Japan Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Korea Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Korea Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure India Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure India Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Southeast Asia Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Southeast Asia Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Australia Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Australia Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Table South America Long-Acting Injectabl Sales by Country (2015-2020)

Figure South America Long-Acting Injectabl Sales Market Share by Country (2015-2020)

Table South America Long-Acting Injectabl Revenue by Country (2015-2020)

Figure South America Long-Acting Injectabl Revenue Market Share by Country (2015-2020)

Figure South America Long-Acting Injectabl Market Share by Type in 2020

Figure South America Long-Acting Injectabl Market Share by Application in 2020

Figure Brazil Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Brazil Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Argentina Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Argentina Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Colombia Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Colombia Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Table Middle East & Africa Long-Acting Injectabl Sales by Country (2015-2020)

Figure Middle East & Africa Long-Acting Injectabl Sales Market Share by Country (2015-2020)

Table Middle East & Africa Long-Acting Injectabl Revenue by Country (2015-2020)

Figure Middle East & Africa Long-Acting Injectabl Revenue Market Share by Country (2015-2020)

Figure Middle East & Africa Long-Acting Injectabl Market Share by Type in 2020

Figure Middle East & Africa Long-Acting Injectabl Market Share by Application in 2020

Figure UAE Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure UAE Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure Saudi Arabia Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure Saudi Arabia Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Figure South Africa Long-Acting Injectabl Sales and Growth Rate (2015-2020)

Figure South Africa Long-Acting Injectabl Revenue (Million $) and Growth Rate (2015-2020)

Table Company Snapshot of Eli Lilly

Table Long-Acting Injectabl Introduction of Eli Lilly

Table Long-Acting Injectabl Sales, Price, Revenue, Gross Margin and Market Share of Eli Lilly (2018-2020)

Table Industrial Chain of Long-Acting Injectabl

Table Manufacturing Cost Structure of Long-Acting Injectabl

Table General Manufacturing Process of Long-Acting Injectabl

Table Leading Distributors/Dealers of Long-Acting Injectabl

Table Leading Consumers of Long-Acting Injectabl

Figure Global Long-Acting Injectabl Sales and Growth Rate Forecast (2021-2030)

Figure Global Long-Acting Injectabl Revenue and Growth Rate Forecast (2021-2030)

Table Global Long-Acting Injectabl Market Size and CAGR Forecast by Region (2021-2030)

Table Global Long-Acting Injectabl Market Size and CAGR Forecast by Type (2021-2030)

Table Global Long-Acting Injectabl Market Size and CAGR Forecast by Application (2021-2030)

Table Global Long-Acting Injectabl Market Size and CAGR Forecast by Sales Channel (2021-2030)

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Our Clients

dropbox
kodak
honeywell
philips
nestle
Hanwha
Compass-Minerals
Elanco
Honda-Europe
Futuremarkets.co | Powered By Upward Media Research, LLP | © 2021